1. Short title This Act may be cited as the Terminate CDC Overreach Act . 2. Limitation on regulations relating to control of communicable diseases (a) Scope of authority Section 361 of the Public Health Service Act ( 42 U.S.C. 264 ) is amended— (1) in subsection (a), by striking of the Secretary and inserting of the Secretary, and subject to subsection (d), ; and (2) in subsection (d)— (A) in paragraph (1), by striking Regulations prescribed under this section may provide for the apprehension and examination of any individual and inserting Subject to paragraph (5), regulations may only be prescribed under this section to prevent the introduction, transmission, or spread of communicable diseases among individuals ; (B) in paragraph (2), in the matter preceding subparagraph (A), by inserting as demonstrated through a positive clinical test, rigorous contact tracing, or clinical presentation after such disease ; and (C) by adding at the end the following: (3) The term clinical test means a test used in the collection, preparation, analysis, or in vitro clinical examination of specimens taken or derived from the human body for purposes of the diagnosis of a particular disease by a health care professional, including any such test that is— (A) designed, manufactured, and used within a single laboratory; or (B) approved, cleared, granted marketing authorization, or authorized for emergency use for such purpose under the Federal Food, Drug, and Cosmetic Act. (4) (A) Effective beginning on the date of the enactment of the Terminate CDC Overreach Act , the Secretary may not, except as specified in subparagraph (B), issue a rule under this section with respect to control of a communicable disease that is unrelated to the prevention of the interstate spread of disease by identifying, isolating, or destroying the disease itself. (B) Subparagraph (A) shall not apply with respect to— (i) the authority of the Secretary to carry out any provision of the Federal Food, Drug, and Cosmetic Act